Added to Saved items
This page has been archived. It has not been updated since 03/05/2016. External links and references may no longer work.
This article is for Medical Professionals

Professional Reference articles are designed for health professionals to use. They are written by UK doctors and based on research evidence, UK and European Guidelines. You may find one of our health articles more useful.

Read COVID-19 guidance from NICE

Treatment of almost all medical conditions has been affected by the COVID-19 pandemic. NICE has issued rapid update guidelines in relation to many of these. This guidance is changing frequently. Please visit to see if there is temporary guidance issued by NICE in relation to the management of this condition, which may vary from the information given below.

Nephrocalcinosis refers to increased calcium content of the kidneys. Nephrocalcinosis usually applies to a generalised increase in renal calcium content rather than the localised increase seen in calcified renal infarction and renal tuberculosis.[1]

Advances in uroendoscopy have led to a further definition: the radiographic demonstration of diffuse, fine renal parenchymal calcifications.[1]

Nephrocalcinosis can be divided into three categories (there is invariably a degree of overlap between the categories):[2]

  • Chemical nephrocalcinosis: increased concentration of calcium in renal cells, especially the tubular epithelium, causing adverse effects on renal structure and function - eg, increased excretion of water, sodium, potassium, calcium and magnesium.
  • Microscopic nephrocalcinosis: calcium precipitates in crystalline form as oxalate and/or phosphate; however, it is only seen with the aid of a microscope.
  • Macroscopic nephrocalcinosis: large areas of calcification can be seen.

Nephrocalcinosis may be associated with renal calculi but is more likely to represent an underlying metabolic disorder. It can also be differentiated into:

  • Medullary nephrocalcinosis:
    • The most frequent form, characterised by the exclusive involvement of the medullary pyramids.
    • It is usually associated with disordered calcium homeostasis.
  • Cortical nephrocalcinosis:
    • Rarer and involving all the renal parenchyma.
    • Frequently associated with severe metabolic defects, such as primary hyperoxaluria or end-stage kidney disease.
    • The most frequent causes are chronic glomerulonephritis and acute cortical necrosis.
    • Other causes include haemolytic uraemic syndrome, chronic pyelonephritis, vesicoureteral reflux, renal transplantation and polycystic kidney disease.

Microscopic nephrocalcinosis is a common incidental finding at post-mortem but macroscopic nephrocalcinosis is uncommon.

Medullary nephrocalcinosis

  • Hypercalcaemia: for example, diet, hyperparathyroidism, vitamin D excess, bone metastases, bone loss from chronic immobilisation and severe osteoporosis, sarcoidosis, idiopathic hypercalcaemia of infancy (Williams' disease).
  • Hypercalciuria:
    • Altered renal tubular handling - eg, idiopathic hypercalciuria, distal renal tubular acidosis (is associated with low urinary excretion of citrate), hypothyroidism, inherited tubular disorders (eg, Bartter's syndrome and familial magnesium-losing nephropathy), and may follow intensive loop diuretic treatment in premature infants.
    • Hypercalciuria is also a feature of Fanconi's syndrome and proximal renal tubular acidosis; however, these conditions are less commonly associated with nephrocalcinosis.
  • Absence of factors in urine (eg, citrate) that help to maintain calcium salts in solution - eg, in conditions causing chronic hypokalaemia (eg, primary hyperaldosteronism).
  • Medullary sponge kidney.[3]

Cortical nephrocalcinosis

  • Acute renal cortical necrosis: causes include infection, extracorporeal shock wave lithotripsy, haemolytic uraemic syndrome.
  • Primary and secondary oxalosis.
  • Chronic glomerulonephritis.
  • Intrarenal infections in HIV-seropositive patients.
  • Chronic pyelonephritis.
  • Renal graft rejection.
  • Autosomal recessive polycystic disease.
  • The underlying aetiology primarily determines the presentation of nephrocalcinosis, although in most cases it is asymptomatic and is identified as an abnormality on imaging of the renal tract.
  • Presentation can range from incidental detection on abdominal X-rays or ultrasounds performed for another reason, to life-threatening.
  • Hypercalcaemia: polyuria and polydipsia, nausea and vomiting.
  • May cause hypertension.
  • In medullary nephrocalcinosis, calcium nodules commonly rupture into the calyceal system to form urinary stones and cause renal colic, haematuria, urinary tract infections or the passage of urinary stones.
  • May rarely present with features of acute kidney injury or chronic kidney disease.

Presenting symptoms in children include failure to thrive in the first year of life, urinary tract infections, bladder voiding dysfunction or abdominal pain, and psychomotor delay.[4]

Blood tests

  • Serum calcium, phosphate, albumin: to establish the presence of hypercalcaemia.
  • Serum electrolytes and assessment of renal function.
  • Parathyroid hormone levels.
  • Thyroid-stimulating hormone (TSH) levels.

Urine investigations

  • Urinalysis with microscopy and culture: evidence of urinary tract infection.
  • 24-hour urinary excretion of calcium, oxalate, citrate and protein: assessment of hypercalciuria and possible nephrotic syndrome.
  • Urinary magnesium: magnesium-losing nephropathy.


  • Abdominal X-rays: detection of nephrocalcinosis, urinary stones.
  • Ultrasound: more sensitive than conventional radiography and can be superior to CT scan in some clinical scenarios (eg, nephrocalcinosis associated with hypoparathyroidism).[5]
  • CT scan: more effective in detecting calcification and can be used to differentiate medullary and cortical deposition.

When calcification in close association with the renal papillae is seen on CT scans, distinguishing nephrolithiasis from nephrocalcinosis may require direct visual inspection using endoscopy.[1]

Renal biopsy
May be required in the assessment of the underlying cause.

Genetic testing
May play an increasing role in nephrocalcinosis presenting in children in the future.[6]

Nephrocalcinosis and urinary calculi may co-exist. Nephrocalcinosis and calcium nephrolithiasis are considered as two independent pathologies.[7]

Common associated conditions include:

  • Primary hyperparathyroidism.
  • Type 1 (distal) renal tubular acidosis.
  • Medullary sponge kidney.
  • Furosemide therapy (neonatal).
  • Increasing prematurity.

Rarer associated conditions include:

  • Phosphate and vitamin D in X-linked hypophosphataemic rickets.
  • Hyperphosphatasia.
  • Sarcoidosis.
  • Tuberculosis.
  • Vitamin D intoxication.
  • Hypomagnesemia.
  • Bartter's syndrome.
  • Glycogen storage disease 1.
  • Prolonged immobilisation.
  • Idiopathic hypercalciuria.
  • Oculocerebral syndrome.
  • Hyperoxaluria.
  • Cushing's syndrome.
  • Hypothyroidism.
  • Acetazolamide.
  • Cerebrotendinous xanthomatosis.
  • Dent's disease.

See also separate Hypercalcaemia article.

  • Ensure adequate fluid intake.
  • Treatment of the underlying condition - eg, parathyroidectomy to control a hyperfunctioning parathyroid gland.
  • Early treatment of reversible causes of renal failure, such as treatment of urinary infections, calculous obstruction and hypertension, is essential.
  • Once renal failure is established, it must be treated accordingly. See separate Acute Kidney Injury and Chronic Kidney Disease articles.
  • Surgical intervention may be required for significant stone formation in the renal tract, especially if causing obstruction or infection.
  • Lithotripsy may cause renal damage, as the calcium deposition is largely parenchymal.

May lead to uncontrolled hypertension, renal infection, scarring, renal colic, defects of renal tubular function and chronic kidney disease.

The prognosis depends mainly on the aetiology of the nephrocalcinosis.

Early diagnosis and treatment of the underlying condition in children is associated with catch-up growth and stabilisation of glomerular function in many children but not with the reduction in the degree of nephrocalcinosis in the majority of cases.[4]

Are you protected against flu?

See if you are eligible for a free NHS flu jab today.

Check now

Further reading and references

  • Mittal K, Anandpara K, Dey AK, et al; An Association of Chronic Hyperaldosteronism with Medullary Nephrocalcinosis. Pol J Radiol. 2015 Sep 580:417-24. doi: 10.12659/PJR.894674. eCollection 2015.

  1. Miller NL, Humphreys MR, Coe FL, et al; Nephrocalcinosis: re-defined in the era of endourology. Urol Res. 2010 Dec38(6):421-7. Epub 2010 Nov 6.

  2. Davison A; Oxford Textbook of Clinical Nephrology Volume 2, 2005.

  3. Schepens D, Verswijvel G, Kuypers D, et al; Images in Nephrology. Renal cortical nephrocalcinosis. Nephrol Dial Transplant. 2000 Jul15(7):1080-2.

  4. Ammenti A, Pelizzoni A, Cecconi M, et al; Nephrocalcinosis in children: a retrospective multi-centre study. Acta Paediatr. 2009 Oct98(10):1628-31. Epub 2009 Jul 1.

  5. Boyce AM, Shawker TH, Hill SC, et al; Ultrasound is superior to computed tomography for assessment of medullary nephrocalcinosis in hypoparathyroidism. J Clin Endocrinol Metab. 2013 Mar98(3):989-94. doi: 10.1210/jc.2012-2747. Epub 2013 Jan 24.

  6. Halbritter J, Baum M, Hynes AM, et al; Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis. J Am Soc Nephrol. 2015 Mar26(3):543-51. doi: 10.1681/ASN.2014040388. Epub 2014 Oct 8.

  7. Vervaet BA, Verhulst A, D'Haese PC, et al; Nephrocalcinosis: new insights into mechanisms and consequences. Nephrol Dial Transplant. 2009 Jul24(7):2030-5. Epub 2009 Mar 18.